Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Mar 15;69(6):2176-9.
doi: 10.1158/0008-5472.CAN-08-3151. Epub 2009 Mar 3.

Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer

Affiliations

Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer

Wennuan Liu et al. Cancer Res. .

Abstract

We searched for deletions in the germ-line genome among 498 aggressive prostate cancer cases and 494 controls from a population-based study in Sweden [CAncer of the Prostate in Sweden (CAPS)] using Affymetrix SNP arrays. By comparing allele intensities of approximately 500,000 SNP probes across the genome, a germ-line deletion at 2p24.3 was observed to be significantly more common in cases (12.63%) than in controls (8.28%); P = 0.028. To confirm the association, we genotyped this germ-line copy number variation (CNV) in additional subjects from CAPS and from Johns Hopkins Hospital (JHH). Overall, among 4,314 cases and 2,176 controls examined, the CNV was significantly associated with prostate cancer risk [odds ratio (OR), 1.25; 95% confidence interval (95% CI), 1.06-1.48; P = 0.009]. More importantly, the association was stronger for aggressive prostate cancer (OR, 1.31; 95% CI, 1.08-1.58; P = 0.006) than for nonaggressive prostate cancer (OR, 1.19; 95% CI, 0.98-1.45; P = 0.08). The biological effect of this germ-line CNV is unknown because no known gene resides in the deletion. Results from this study represent the first novel germ-line CNV that was identified from a genome-wide search and was significantly, but moderately, associated with prostate cancer risk. Additional confirmation of this association and functional studies are warranted.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Detection of a germline deletion at chromosome 2p24.3. 1a, Examples of results from Affymetrix 500K SNP arrays (only Sty array is shown). Allele intensity data of a number of SNPs at 22p24.3 for subject 667 are shown at the top. A heat map of these SNPs generated using dChip for subject 667 and other subjects is shown below. Evidence for a deletion involving five consecutive SNPs is observed (blue bars) in multiple subjects. 1b, An example DNA sequence illustrates the location of the 5,947 bp deletion (orange arrow) that occurs in all 80 samples examined. 1c, Gel electrophoresis displays PCR fragments representing the deletion (1,136 bp, top, black arrow) and the wild type (590 bp, bottom, black arrow) of this CNV locus. Red, purple, and blue arrows indicate subjects with the homozygous deletion, hemizygous deletion, and homozygous wildtype, respectively. A green arrow indicates the negative control.

Similar articles

Cited by

References

    1. Sebat J, Lakshmi B, Troge J, et al. Large-scale copy number polymorphism in the human genome. Science. 2004;305:525–8. - PubMed
    1. Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet. 2004;36:949–51. - PubMed
    1. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444:444–54. - PMC - PubMed
    1. Tuzun E, Sharp AJ, Bailey JA, et al. Fine-scale structural variation of the human genome. Nat Genet. 2005;37:727–32. - PubMed
    1. Conrad DF, Andrews TD, Carter NP, Hurles ME, Pritchard JK. High-resolution survey of deletion polymorphism in the human genome. Nat Genet. 2006;38:75–81. - PubMed

Publication types